Notify me when DME Capital Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| COYA | Coya Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $8,901,262 | 1,651,440 | DME Advisors GP, L.L.C. | 31 Dec 2024 | ||
| CNR | Core Natural Resources, Inc. | Common Stock, par value $0.01 per share | 4.8% | $98,842,163 | 1,411,426 | DME Advisors GP, L.L.C. | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|